Year To Quarter End Consolidated Statement Of Comprehensive Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7724353

Concept 2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
18,974,000,000 JPY
19,043,000,000 JPY
18,974,000,000 JPY
18,974,000,000 JPY
18,974,000,000 JPY
21,940,000,000 JPY
22,017,000,000 JPY
21,940,000,000 JPY
21,940,000,000 JPY
21,940,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
898,000,000 JPY
187,000,000 JPY
Remeasurements of defined benefit plans, net of tax
811,000,000 JPY
382,000,000 JPY
Other comprehensive income
1,710,000,000 JPY
570,000,000 JPY
Comprehensive income
20,753,000,000 JPY
22,587,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
20,753,000,000 JPY
22,587,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.